BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22124971)

  • 1. In vivo evaluation in cynomolgus monkey brain and metabolism of [¹⁸F]fluorodeprenyl: a new MAO-B pet radioligand.
    Nag S; Varrone A; Tóth M; Thiele A; Kettschau G; Heinrich T; Lehmann L; Halldin C
    Synapse; 2012 Apr; 66(4):323-30. PubMed ID: 22124971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo and In Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, 18F-Labeled Deuterated Fluorodeprenyl.
    Nag S; Fazio P; Lehmann L; Kettschau G; Heinrich T; Thiele A; Svedberg M; Amini N; Leesch S; Catafau AM; Hannestad J; Varrone A; Halldin C
    J Nucl Med; 2016 Feb; 57(2):315-20. PubMed ID: 26585057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a novel fluorine-18 labeled deuterated fluororasagiline ([(18)F]fluororasagiline-D2) radioligand for PET studies of monoamino oxidase B (MAO-B).
    Nag S; Lehmann L; Kettschau G; Toth M; Heinrich T; Thiele A; Varrone A; Halldin C
    Bioorg Med Chem; 2013 Nov; 21(21):6634-41. PubMed ID: 24012376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of [¹⁸F]fluororasagiline, a novel positron emission tomography (PET) radioligand for monoamine oxidase B (MAO-B).
    Nag S; Lehmann L; Kettschau G; Heinrich T; Thiele A; Varrone A; Gulyas B; Halldin C
    Bioorg Med Chem; 2012 May; 20(9):3065-71. PubMed ID: 22436387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of novel propargyl amines as potential fluorine-18 labeled radioligands for detection of MAO-B activity.
    Nag S; Kettschau G; Heinrich T; Varrone A; Lehmann L; Gulyas B; Thiele A; Keller É; Halldin C
    Bioorg Med Chem; 2013 Jan; 21(1):186-95. PubMed ID: 23211968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine oxidase B inhibitor, selegiline, reduces
    Ng KP; Pascoal TA; Mathotaarachchi S; Therriault J; Kang MS; Shin M; Guiot MC; Guo Q; Harada R; Comley RA; Massarweh G; Soucy JP; Okamura N; Gauthier S; Rosa-Neto P
    Alzheimers Res Ther; 2017 Mar; 9(1):25. PubMed ID: 28359327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo measurement of brain monoamine oxidase B occupancy by rasagiline, using (11)C-l-deprenyl and PET.
    Freedman NM; Mishani E; Krausz Y; Weininger J; Lester H; Blaugrund E; Ehrlich D; Chisin R
    J Nucl Med; 2005 Oct; 46(10):1618-24. PubMed ID: 16204711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of three novel fluorine-18 labeled analogues of L-deprenyl for positron emission tomography (PET) studies of monoamine oxidase B (MAO-B).
    Nag S; Lehmann L; Heinrich T; Thiele A; Kettschau G; Nakao R; Gulyás B; Halldin C
    J Med Chem; 2011 Oct; 54(20):7023-9. PubMed ID: 21923198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pro-psychotic metabotropic glutamate receptor compounds fenobam and AZD9272 share binding sites with monoamine oxidase-B inhibitors in humans.
    Varnäs K; Cselényi Z; Arakawa R; Nag S; Stepanov V; Moein MM; Johnström P; Kingston L; Elmore CS; Halldin C; Farde L
    Neuropharmacology; 2020 Jan; 162():107809. PubMed ID: 31589885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for reduced arterial plasma input, prolonged lung retention and reduced lung monoamine oxidase in smokers.
    Logan J; Fowler JS
    Nucl Med Biol; 2005 Jul; 32(5):521-9. PubMed ID: 15982583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and preclinical evaluation of [
    Dahl K; Bernard-Gauthier V; Nag S; Varnäs K; Narayanaswami V; Mahdi Moein M; Arakawa R; Vasdev N; Halldin C
    Bioorg Med Chem Lett; 2019 Jul; 29(13):1624-1627. PubMed ID: 31060887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET.
    Fowler JS; MacGregor RR; Wolf AP; Arnett CD; Dewey SL; Schlyer D; Christman D; Logan J; Smith M; Sachs H
    Science; 1987 Jan; 235(4787):481-5. PubMed ID: 3099392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of new radiopharmaceuticals for imaging monoamine oxidase B.
    Vasdev N; Sadovski O; Moran MD; Parkes J; Meyer JH; Houle S; Wilson AA
    Nucl Med Biol; 2011 Oct; 38(7):933-43. PubMed ID: 21982565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the metabolites of (S,S)-[(11)C]MeNER in humans, monkeys and rats.
    Schou M; Zoghbi SS; Shetty HU; Shchukin E; Liow JS; Hong J; Andrée BA; Gulyás B; Farde L; Innis RB; Pike VW; Halldin C
    Mol Imaging Biol; 2009; 11(1):23-30. PubMed ID: 18800204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [(11)C]SL25.1188, a new reversible radioligand to study the monoamine oxidase type B with PET: preclinical characterisation in nonhuman primate.
    Saba W; Valette H; Peyronneau MA; Bramoullé Y; Coulon C; Curet O; George P; Dollé F; Bottlaender M
    Synapse; 2010 Jan; 64(1):61-9. PubMed ID: 19728365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic positron emission tomography studies: demonstration of a deuterium isotope effect in the monoamine oxidase-catalyzed binding of [11C]L-deprenyl in living baboon brain.
    Fowler JS; Wolf AP; MacGregor RR; Dewey SL; Logan J; Schlyer DJ; Langstrom B
    J Neurochem; 1988 Nov; 51(5):1524-34. PubMed ID: 3139834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography.
    Gulyás B; Pavlova E; Kása P; Gulya K; Bakota L; Várszegi S; Keller E; Horváth MC; Nag S; Hermecz I; Magyar K; Halldin C
    Neurochem Int; 2011 Jan; 58(1):60-8. PubMed ID: 21075154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-in-Humans Evaluation of
    Villemagne VL; Harada R; Doré V; Furumoto S; Mulligan R; Kudo Y; Burnham S; Krishnadas N; Bozinovski S; Huang K; Lopresti BJ; Yanai K; Rowe CC; Okamura N
    J Nucl Med; 2022 Oct; 63(10):1551-1559. PubMed ID: 35086898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET Evaluation of the Novel F-18 Labeled Reversible Radioligand [
    Varnäs K; Nag S; Halldin C; Farde L
    ACS Chem Neurosci; 2023 Sep; 14(17):3206-3211. PubMed ID: 37587571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of N-[3-(2',4'-dichlorophenoxy)-2-18F-fluoropropyl]-N-methylpropargylamine (18F-fluoroclorgyline) as a potential PET radiotracer for monoamine oxidase-A.
    Mukherjee J; Yang ZY
    Nucl Med Biol; 1999 Aug; 26(6):619-25. PubMed ID: 10587099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.